T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Remitly
RELY
$5.33B
| $62.6M | 0.01% |
3,841,474
+3,676,768
| +2,232% | +$66M |
|
727
Globus Medical
GMED
$11.5B
| $62.5M | 0.01% |
1,091,732
+17,066
| +2% | +$983K |
|
728
Okta
OKTA
$26.9B
| $62.5M | 0.01% |
681,142
-588,433
| -46% | -$54.9M |
|
729
PBF Energy
PBF
$8.78B
| $62.4M | 0.01% |
2,069,298
+1,987,363
| +2,426% | +$51.9M |
|
730
Pebblebrook Hotel Trust
PEB
$2.05B
| $62.3M | 0.01% |
5,469,758
+2,027,011
| +59% | +$21.8M |
|
731
Post Holdings
POST
$3.68B
| $62.2M | 0.01% |
579,033
+11,428
| +2% | +$1.23M |
|
732
US Foods
USFD
$23.8B
| $62.2M | 0.01% |
812,215
+19,140
| +2% | +$1.52M |
|
733
UL Solutions
ULS
$15.5B
| $62.1M | 0.01% |
876,734
+856,645
| +4,264% | +$58.4M |
|
734
Payoneer
PAYO
$2.42B
| $62M | 0.01% |
10,253,856
+242,823
| +2% | +$1.63M |
|
735
Celldex Therapeutics
CLDX
$3.39B
| $61.6M | 0.01% |
2,382,518
-1,435,302
| -38% | -$33.3M |
|
736
Boston Properties
BXP
$11.1B
| $61.5M | 0.01% |
827,103
+617,885
| +295% | +$43.6M |
|
737
New York Times
NYT
$10.4B
| $61.4M | 0.01% |
1,070,054
+948,220
| +778% | +$54.1M |
|
738
OSI Systems
OSIS
$3.78B
| $61M | 0.01% |
244,918
+190,806
| +353% | +$43.6M |
|
739
IDEX
IEX
$17.6B
| $60.9M | 0.01% |
374,124
-1,640,644
| -81% | -$277M |
|
740
Eagle Materials
EXP
$6.4B
| $60.9M | 0.01% |
261,158
+1,591
| +0.6% | +$361K |
|
741
Zebra Technologies
ZBRA
$18B
| $60.8M | 0.01% |
204,704
-88,517
| -30% | -$28.3M |
|
742
Vaxcyte
PCVX
$8.81B
| $60.8M | 0.01% |
1,688,483
-1,481,764
| -47% | -$49.1M |
|
743
Iron Mountain
IRM
$37.6B
| $60.7M | 0.01% |
595,595
-31,445
| -5% | -$3.03M |
|
744
Public Service Enterprise Group
PEG
$37.8B
| $60.7M | 0.01% |
727,138
+3,970
| +0.5% | +$333K |
|
745
Halozyme
HALO
$11.4B
| $60.5M | 0.01% |
825,425
-206,768
| -20% | -$13.7M |
|
746
Pool Corp
POOL
$7.32B
| $60.5M | 0.01% |
195,206
-34,890
| -15% | -$10.9M |
|
747
Target
TGT
$70.6B
| $60.2M | 0.01% |
671,038
-3,118
| -0.5% | -$307K |
|
748
Regions Financial
RF
$26.9B
| $60.1M | 0.01% |
2,277,901
+21,821
| +1% | +$567K |
|
749
Enpro
NPO
$7.1B
| $60M | 0.01% |
265,281
+244,687
| +1,188% | +$52.8M |
|
750
Kroger
KR
$35.2B
| $59.6M | 0.01% |
884,713
-15,161
| -2% | -$1.06M |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.